Table 1.
The basic clinical data of enrolled participants
| Characteristics (n [%]or median [IQR]) |
PJP patients (N = 33) |
Non-PJP patients (N = 34) |
Statistical value | P value |
|---|---|---|---|---|
| Male | 20 (60.61) | 24 (70.59) | 0.740 | 0.390 |
| Age (years) | 61 (48,67) | 61 (50,69) | − 0.217 | 0.829 |
| Underlying illnesses | ||||
| Diabetes mellitus | 8 (24.24) | 7 (20.59) | 0.129 | 0.720 |
| Hypertension | 12 (36.36) | 12 (35.29) | 0.008 | 0.927 |
| Chronic pulmonary disease | 14 (42.42) | 7 (20.59) | 3.711 | 0.054 |
| Chronic heart failure | 1 (3.03) | 1 (2.94) | – | 1.000 |
| Immunocompromised conditions | ||||
| Solid organ transplantation | 4 (12.12) | 0 (0) | 2.490 | 0.115 |
| Hematologic malignancies | 2 (6.06) | 2 (5.88) | 0.000 | 1.000 |
| Rheumatic diseases | 15 (45.45) | 16 (47.06) | 0.017 | 0.895 |
| Solid organ tumors | 6 (18.18) | 13 (38.24) | 3.315 | 0.069 |
| Glomerulonephritis or nephrotic syndrome | 3 (9.09) | 2 (5.88) | 0.001 | 0.972 |
| Other types of immunocompromised disease | 3 (9.09) | 1 (2.94) | 0.299 | 0.585 |
| Use of corticosteroids only | 7 (21.21) | 3 (9.09) | 1.166 | 0.280 |
| Use of immunosuppressants only | 3 (9.09) | 3 (9.09) | 0.000 | 1.000 |
| Corticosteroids with immunosuppressants | 14 (42.42) | 2 (5.88) | 12.302 | 0.000 |
| PJP prophylaxis | 1 (3.03) | 2 (5.88) | 0.000 | 1.000 |
PJP Pneumocystis jirovecii Pneumonia